Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06242379 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa

StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Feb 2025 to Dec 31, 2026 Completion date: Feb 2026 to Dec 31, 2027v5 Show 1 more changeShow less
    • Completion date: Feb 2026 to Dec 31, 2027
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Sep 1, 2024 to May 23, 2024 · Site details revisedv4 Show 2 more changesShow less
    • Start date changed from estimate of Sep 1, 2024 to May 23, 2024
    • Site details revised
  3. Primary endpoints: 10 to 12v3 See this version in full on ClinicalTrials.gov ↗
  4. Eligibility criteria expanded, about 6 words Study description expanded, about 3 wordsv2 Show 1 more changeShow less
    • Study description expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this clinical trials is to evaluate the safety and efficacy of intravitreal injection of GMP-compliant BM-MSC-derived sEVs in patients with retinitis pigmentosa.
Trial Details
NCT Number NCT06242379
Lead Sponsor Mahidol University
Conditions Retinitis Pigmentosa
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov